<div class="m-3 h-100">
  <ul class="nav nav-tabs bg-blueopal" id="myTab" role="tablist">
  <li class="nav-item">
    <a class="nav-link active" id="home-tab" data-toggle="tab" href="#home" role="tab" aria-controls="home" aria-selected="true">Home</a>
  </li>
  <li class="nav-item">
    <a class="nav-link" id="national-RPP-PSMF-requirements-tab" data-toggle="tab" href="#national-RPP-PSMF-requirements" role="tab" aria-controls="national-RPP-PSMF-requirements" aria-selected="false">National RPP-PSMF requirements</a>
  </li>
  <li class="nav-item">
    <a class="nav-link" id="national-expedited-reporting-rules-tab" data-toggle="tab" href="#national-expedited-reporting-rules" role="tab" aria-controls="national-expedited-reporting-rules" aria-selected="false">National Expedited Reporting rules</a>
  </li>
  <li class="nav-item">
    <a class="nav-link" id="national-periodic-reporting-requirements-tab" data-toggle="tab" href="#national-periodic-reporting-requirements" role="tab" aria-controls="national-periodic-reporting-requirements" aria-selected="false">National Periodic Reporting requirements</a>
  </li>
  <li class="nav-item">
   <a class="nav-link" id="responsibiilty-per-country-tab" data-toggle="tab" href="#responsibiilty-per-country" role="tab" aria-controls="responsibiilty-per-country" aria-selected="false">Summary</a>  <!-- of responsibility per country for the CT safety reporting obligations -->
  </li>
  <li class="nav-item">
    <a class="nav-link" id="national-rmp-requirements-tab" data-toggle="tab" href="#national-rmp-requirements" role="tab" aria-controls="national-rmp-requirements" aria-selected="false">National RMP requirements</a>
  </li>
</ul>
<div class="tab-content" id="nav-tabContent">
  <div class="tab-pane fade show active" id="home" role="tabpanel" aria-labelledby="home-tab">
    
    <div class="row h-100 ">

      <div class="col-md-8 mb-2">
          <div class="card mb-2">
              <div class="card-group-item">
                  <header class="card-header bg-blueopal ">
                      Pharmacovigilance Regulatory Framework
                  </header>
                  <div class="filter-content">
                      <div class="card-body">
                          Lorem Ipsum is simply dummy text of the printing and typesetting
                          industry. Lorem Ipsum has been the industry's standard dummy text
                          ever since the 1500s, when an unknown printer took a galley of type
                          and scrambled it to make a type specimen book. It has survived not
                          only five centuries, but also the leap into electronic typesetting,
                          remaining essentially unchanged. It was popularised in the 1960s
                          with the release of Letraset sheets containing Lorem Ipsum passages,
                          and more recently with desktop publishing software like Aldus
                          PageMaker including versions of Lorem Ipsum.
                      </div>
                  </div>
              </div>
          </div>
          <div class="card">
              <div class="card-group-item">
                  <header class="card-header bg-blueopal ">
                      Map
                  </header>
                  <div class="filter-content" id="map">
                      <div class="card-body text-center">
                        <div id="vmap" style="width: 100%; height: 400px;"></div>
                      </div>
                  </div>
              </div>
          </div>
      </div>
      <div class="col-md-2">
          <div class="card mb-1">
              <div class="card-group-item">
                  <header class="card-header bg-blueopal ">
                      National Safety Regulatory Requirements
                  </header>
                  <div class="filter-content">
                      <div class="card-body">
                          <div class="card bg-default text-center mb-2">
                              <div class="card-body">
                                  <div class="row align-items-center">
                                      <div class="col">
                                          <a id="national-RPP-PSMF-requirements-tab" data-toggle="tab"
                                              href="#national-RPP-PSMF-requirements" role="tab"
                                              aria-controls="national-RPP-PSMF-requirements"
                                              aria-selected="false">National RPP-PSMF requirements</a>
                                      </div>
                                  </div>
                              </div>
                          </div>
                          <div class="card bg-default text-center mb-2">
                              <div class="card-body">
                                  <div class="row align-items-center">
                                      <div class="col">
                                          <a id="national-expedited-reporting-rules-tab" data-toggle="tab"
                                              href="#national-expedited-reporting-rules" role="tab"
                                              aria-controls="national-expedited-reporting-rules"
                                              aria-selected="false">National Expedited Reporting rules</a>
                                      </div>
                                  </div>
                              </div>
                          </div>
                          <div class="card bg-default text-center mb-2">
                              <div class="card-body">
                                  <div class="row align-items-center">
                                      <div class="col">
                                          <a id="national-periodic-reporting-requirements-tab"
                                              data-toggle="tab"
                                              href="#national-periodic-reporting-requirements" role="tab"
                                              aria-controls="national-periodic-reporting-requirements"
                                              aria-selected="false">National Periodic Reporting
                                              requirements</a>
                                      </div>
                                  </div>
                              </div>
                          </div>
                          <div class="card bg-default text-center mb-2">
                              <div class="card-body">
                                  <div class="row align-items-center">
                                      <div class="col">
                                          <a id="responsibiilty-per-country-tab" data-toggle="tab"
                                              href="#responsibiilty-per-country" role="tab"
                                              aria-controls="responsibiilty-per-country"
                                              aria-selected="false">Summary
                                              of responsibility per country for the CT safety reporting
                                              obligations</a>
                                      </div>
                                  </div>
                              </div>
                          </div>
                          <div class="card bg-default text-center mb-2">
                              <div class="card-body">
                                  <div class="row align-items-center">
                                      <div class="col">
                                          <a id="national-rmp-requirements-tab" data-toggle="tab"
                                              href="#national-rmp-requirements" role="tab"
                                              aria-controls="national-rmp-requirements"
                                              aria-selected="false">National
                                              RMP requirements </a>
                                      </div>
                                  </div>
                              </div>
                          </div>
                      </div>
                  </div>
              </div>
          </div>
          
      </div>
      <div class="col-md-2">
        <div class="p-3 mb-2 bg-blueopal">Region/Country</div>
        <div class="mb-2">
            <div class="panel-group" id="accordion" role="tablist" aria-multiselectable="true">
                    <div class="panel panel-default">
                        <div class="panel-heading" role="tab" id="headingOne">
                            <h4 class="panel-title">
                                <a role="button" data-toggle="collapse" data-parent="#accordion" href="#collapseOne" aria-expanded="true" aria-controls="collapseOne">
                                    AEGIS <span class="badge badge-info">1</span>
                                </a>
                            </h4>
                        </div>
                        <div id="collapseOne" class="panel-collapse collapse in" role="tabpanel" aria-labelledby="headingOne">
                            <div class="panel-body">
                                <ul class="list-group list-group-flush">
                                    <li class="list-group-item">AEGIS </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                    <div class="panel panel-default">
                        <div class="panel-heading" role="tab" id="headingTwo">
                            <h4 class="panel-title">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
                                    Africa, Middle East and Eurasia <span class="badge badge-info">32</span>
                                </a>
                            </h4>
                        </div>
                        <div id="collapseTwo" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingTwo">
                            <div class="panel-body">
                                <ul class="list-group list-group-flush">
                                    <li class="list-group-item">Afghanistan</li>
                                    <li class="list-group-item">Algeria </li>
                                    <li class="list-group-item">Angola </li>
                                    <li class="list-group-item">Armenia </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                    <div class="panel panel-default">
                        <div class="panel-heading" role="tab" id="headingThree">
                            <h4 class="panel-title">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapseThree" aria-expanded="false" aria-controls="collapseThree">
                                    AMERICAS  <span class="badge badge-info">1</span>
                                </a>
                            </h4>
                        </div>
                        <div id="collapseThree" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingThree">
                            <div class="panel-body">
                                <ul class="list-group list-group-flush">
                                    <li class="list-group-item">Afghanistan</li>
                                    <li class="list-group-item">Algeria </li>
                                    <li class="list-group-item">Angola </li>
                                    <li class="list-group-item">Armenia </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                    <div class="panel panel-default">
                        <div class="panel-heading" role="tab" id="headingFour">
                            <h4 class="panel-title">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapseFour" aria-expanded="false" aria-controls="collapseFour">
                                    Asia, China and JPAC  <span class="badge badge-info">23</span>
                                </a>
                            </h4>
                        </div>
                        <div id="collapseFour" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingFour">
                            <div class="panel-body">
                                <ul class="list-group list-group-flush">
                                    <li class="list-group-item">Afghanistan</li>
                                    <li class="list-group-item">Algeria </li>
                                    <li class="list-group-item">Angola </li>
                                    <li class="list-group-item">Armenia </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                    <div class="panel panel-default">
                        <div class="panel-heading" role="tab" id="headingFive">
                            <h4 class="panel-title">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapseFive" aria-expanded="false" aria-controls="collapseFive">
                                    Europe  <span class="badge badge-info">1 </span>
                                </a>
                            </h4>
                        </div>
                        <div id="collapseFive" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingFive">
                            <div class="panel-body">
                                <ul class="list-group list-group-flush">
                                    <li class="list-group-item">Afghanistan</li>
                                    <li class="list-group-item">Algeria </li>
                                    <li class="list-group-item">Angola </li>
                                    <li class="list-group-item">Armenia </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                    <div class="panel panel-default">
                        <div class="panel-heading" role="tab" id="headingSix">
                            <h4 class="panel-title">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapseSix" aria-expanded="false" aria-controls="collapseSix">
                                    Europe EEA   <span class="badge badge-info">31  </span>
                                </a>
                            </h4>
                        </div>
                        <div id="collapseSix" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingSix">
                            <div class="panel-body">
                                <ul class="list-group list-group-flush">
                                    <li class="list-group-item">Afghanistan</li>
                                    <li class="list-group-item">Algeria </li>
                                    <li class="list-group-item">Angola </li>
                                    <li class="list-group-item">Armenia </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                    <div class="panel panel-default">
                        <div class="panel-heading" role="tab" id="headingSeven">
                            <h4 class="panel-title">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapseSeven" aria-expanded="false" aria-controls="collapseSeven">
                                    Europe non EEA  <span class="badge badge-info">8  </span>
                                </a>
                            </h4>
                        </div>
                        <div id="collapseSeven" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingSeven">
                            <div class="panel-body">
                                <ul class="list-group list-group-flush">
                                    <li class="list-group-item">Afghanistan</li>
                                    <li class="list-group-item">Algeria </li>
                                    <li class="list-group-item">Angola </li>
                                    <li class="list-group-item">Armenia </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
      </div>
  </div>
  </div>
  <div class="tab-pane fade" id="national-RPP-PSMF-requirements" role="tabpanel" aria-labelledby="national-RPP-PSMF-requirements-tab">
    <div class="mt-2">
      <ul class="nav nav-pills mb-3" id="pills-tab" role="tablist">
          <li class="nav-item success">
              <a class="nav-link active" id="pills-RPP-PSMF-tab" data-toggle="pill"
                  href="#pills-RPP-PSMF" role="tab" aria-controls="pills-RPP-PSMF"
                  aria-selected="true">RPP-PSMF rqmt</a>
          </li>
          <li class="nav-item">
              <a class="nav-link" id="pills-RPP-Status-tab" data-toggle="pill"
                  href="#pills-RPP-Status" role="tab" aria-controls="pills-RPP-Status"
                  aria-selected="false">RPP rqmt status</a>
          </li>
          <li class="nav-item">
              <a class="nav-link" id="pills-Feuil2-tab" data-toggle="pill"
                  href="#pills-Feuil2" role="tab" aria-controls="pills-Feuil2"
                  aria-selected="false">Feuil2</a>
          </li>
          <li class="nav-item">
              <a class="nav-link" id="pills-Feuil1-tab" data-toggle="pill"
                  href="#pills-Feuil1" role="tab" aria-controls="pills-Feuil1"
                  aria-selected="false">Feuil1</a>
          </li>
      </ul>
      <div class="tab-content" id="pills-tabContent">
          <div class="tab-pane fade show active" id="pills-RPP-PSMF" role="tabpanel" aria-labelledby="pills-RPP-PSMF-tab">
              <h4 class="mb-3"> Medical Products including Vaccines - Responsible
                  Pharmacovigilance Person / Pharmacovigilance System Master File (PSMF)
                  Requirements </h4>

                  <div class="alert alert-success alert-dismissible fade show" role="alert" style="font-size:13px">
                          <p><b>Regional Responsible Person in Pharmacovigilance</b> = Contact person overseeing the Marketing Authorization Holder PV system across the countries of a region where the product is approved  (e.g Qualified Person for Pharmacovigilance-QPPV in EU) under regional and/or national law <br>
                              <b>Responsible person in Pharmacovigilance (RPP)</b> = Contact person overseeing the Marketing Authorization Holder PV system from the country where the product is approved  (e.g. QPPV in a country/ PV representative/PV responsible person)  under the law of the country
                          </p>
                      </div>
              <!--<div class="table-responsive">-->
                  <table id="dtHorizontal" class="table table-hover table-striped pharma_table">
                      <thead>
                          <tr>
                              <th>Region</th>
                              <th style="width:100px">Country</th>
                              <th>MAH safety requirements <br> (SRC) with RPP Status when <br>
                                  required [YES/YES-RPP/NO]</th>
                              <th>Regional RPP Required [YES/NO]</th>
                              <th>Local RPP Required [YES/NO]</th>
                              <th>Location (If RPP required for the country)</th>
                              <th>Local Qualification required [YES/NO]</th>
                              <th>PSMF required [YES/NO]</th>
                              <th>Submission of SPS required [YES/NO]</th>
                              <th style="width:400px">Comment (Legislation wording for RPP,
                                  RPP qualification,
                                  PSMF
                                  requirements...)</th>
                              <th>Date of Review at global</th>
                              <th>Local review/ validation / confirmation date</th>
                          </tr>
                      </thead>
                      <tbody>
                          <tr>
                              <td>Africa, Middle East & Eurasia</td>
                              <td><img src="assets/images/flags/af.png" class="table_flag" />
                                  Afghanistan
                              </td>
                              <td>YES</td>
                              <td>NO</td>
                              <td>NO</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>1-Aug-2016</td>
                              <td></td>
                          </tr>
                          <tr>
                              <td>Europe non EEA</td>
                              <td><img src="assets/images/flags/al.png" class="table_flag" /> Albania
                              </td>
                              <td>YES-RPP</td>
                              <td>NO</td>
                              <td>YES</td>
                              <td>Tirana,Albania</td>
                              <td>YES</td>
                              <td>NO</td>
                              <td>NO</td>
                              <td>Responsible person (doctor, pharcist, dentist) only for
                                  Pharmacovigilance should be officaly appointed.</td>
                              <td>10-Dec-2013</td>
                              <td>10-Dec-2013</td>
                          </tr>
                          <tr>
                              <td>Africa, Middle East & Eurasia</td>
                              <td><img src="assets/images/flags/dz.png" class="table_flag" /> Algeria
                              </td>
                              <td>YES</td>
                              <td>NO</td>
                              <td>NO</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>NO</td>
                              <td>NO</td>
                              <td></td>
                              <td>10-Aor-2013</td>
                              <td></td>
                          </tr>
                          <tr>
                              <td>Africa, Middle East & Eurasia</td>
                              <td><img src="assets/images/flags/ao.png" class="table_flag" /> Angola
                              </td>
                              <td>YES</td>
                              <td>NO</td>
                              <td>NO</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>NA</td>
                              <td>10-Dec-2013</td>
                              <td>10-Dec-2013</td>
                          </tr>
                          <tr>
                              <td>Americas</td>
                              <td><img src="assets/images/flags/ar.png" class="table_flag" /> Argentina
                              </td>
                              <td>YES-RPP</td>
                              <td>NO</td>
                              <td>YES</td>
                              <td>must reside in Argentina</td>
                              <td>YES</td>
                              <td>NO</td>
                              <td>NO</td>
                              <td>
                                  Training and experience in PV and notifiy ANMAT this
                                  professional. If no medical qualification, he/she must <br>
                                  Legislation does not
                                  specify the professsional qualifications, but the yrecommend
                                  a
                                  specialist in Pharmacoepidemiology (doctor or pharmacist).
                                  <br>
                                  have access to a persion with such qualification within his
                                  work
                                  team, as the medical terminology must be correctly construed
                                  and
                                  analyzed.<br>
                                  For vacines: recommendation to have a physician specialized
                                  in
                                  infectious diseases.
                              </td>
                              <td>10-Dec-2013</td>
                              <td>10-Dec-2013</td>
                          </tr>
                      </tbody>
                  </table>
              <!--</div>-->

          </div>
          <div class="tab-pane fade" id="pills-RPP-Status" role="tabpanel"
              aria-labelledby="pills-RPP-Status-tab">
              <div class="table-responsive">
                  <table class="table table-hover table-striped pharma_table">
                      <thead>
                          <tr>
                              <th>Nombre de Country <br> Region</th>
                              <th>Local RPP required [YES/NO]</th>
                              <th>Upon request</th>
                              <th>NO (only EI QPPV)</th>
                              <th>Planned</th>
                              <th>NO</th>
                              <th>Total général</th>
                          </tr>
                      </thead>
                      <tbody>
                          <tr>
                              <td>Africa, Middle East & Eurasia</td>
                              <td>26</td>
                              <td></td>
                              <td></td>
                              <td>2</td>
                              <td></td>
                              <td>54</td>
                              <td>82</td>
                          </tr>
                          <tr>
                              <td>Americas</td>
                              <td>15</td>
                              <td></td>
                              <td></td>
                              <td></td>
                              <td></td>
                              <td>16</td>
                              <td>31</td>
                          </tr>
                          <tr>
                              <td>Asia, China & JPAC</td>
                              <td>15</td>
                              <td></td>
                              <td></td>
                              <td></td>
                              <td></td>
                              <td>16</td>
                              <td>31</td>
                          </tr>
                          <tr>
                              <td>Europe EEA</td>
                              <td>20</td>
                              <td>4</td>
                              <td>5</td>
                              <td></td>
                              <td></td>
                              <td>2</td>
                              <td>31</td>
                          </tr>
                          <tr>
                              <td>Europe non EEA</td>
                              <td>7</td>
                              <td></td>
                              <td></td>
                              <td></td>
                              <td></td>
                              <td>1</td>
                              <td>8</td>
                          </tr>
                          <tr class="table-secondary bold">
                              <td>Total général</td>
                              <td>81</td>
                              <td>4</td>
                              <td>5</td>
                              <td>5</td>
                              <td>2</td>
                              <td>83</td>
                              <td>175</td>
                          </tr>
                      </tbody>
                  </table>
              </div>

              <img src="/assets/images/RPP-Status.PNG" />
          </div>
          <div class="tab-pane fade" id="pills-Feuil2" role="tabpanel"
              aria-labelledby="pills-Feuil2-tab">
              <table class="table table-hover table-striped pharma_table">
                  <thead>
                      <tr>
                          <th>Nombre de Country </th>
                          <th>MAH safety required</th>
                          <th>Table</th>
                          <th>Total</th>
                      </tr>
                  </thead>
                  <tbody>
                      <tr>
                          <td>Afghanistan</td>
                          <td>YES</td>
                          <td>DIR<br> LEG <br> RPP</td>
                          <td>1<br> 1 <br> 1</td>
                      </tr>
                      <tr>
                          <td>Albania</td>
                          <td>YES</td>
                          <td>LEG <br> RPP</td>
                          <td> 1 <br> 1</td>
                      </tr>
                      <tr>
                          <td>Algeria</td>
                          <td>YES</td>
                          <td>DIR<br> LEG <br> RPP</td>
                          <td>1<br> 1 <br> 1</td>
                      </tr>
                      <tr>
                          <td>Angola</td>
                          <td>NO</td>
                          <td>DIR<br> LEG <br> RPP</td>
                          <td>1<br> 1 <br> 1</td>
                      </tr>
                      <tr>
                          <td>Argentina</td>
                          <td>YES</td>
                          <td>LEG <br> RPP</td>
                          <td> 1 <br> 1</td>
                      </tr>

                  </tbody>
              </table>
          </div>
          <div class="tab-pane fade" id="pills-Feuil1" role="tabpanel"
              aria-labelledby="pills-Feuil1-tab">
              <table class="table table-hover table-striped pharma_table">
                  <thead>
                      <tr>
                          <th>Region</th>
                          <th>Country</th>
                          <th>MAH safety required (SRC) [YES/NO]</th>
                          <th>Table</th>
                      </tr>
                  </thead>
                  <tbody>
                      <tr>
                          <td>Africa, Middle East & Eurasia</td>
                          <td>Afghanistan</td>
                          <td>YES</td>
                          <td>RPP</td>
                      </tr>
                      <tr>
                          <td>Europe non EEA</td>
                          <td>Albania</td>
                          <td>YES</td>
                          <td>RPP</td>
                      </tr>
                      <tr>
                          <td>Africa, Middle East & Eurasia</td>
                          <td>Algeria</td>
                          <td>YES</td>
                          <td>RPP</td>
                      </tr>
                      <tr>
                          <td>Africa, Middle East & Eurasia</td>
                          <td>Angola</td>
                          <td>NO</td>
                          <td>RPP</td>
                      </tr>
                      <tr>
                          <td>Americas</td>
                          <td>Argentina</td>
                          <td>YES</td>
                          <td>RPP</td>
                      </tr>

                  </tbody>
              </table>
          </div>
      </div>
  </div>
  </div>
  <div class="tab-pane fade" id="national-expedited-reporting-rules" role="tabpanel" aria-labelledby="national-expedited-reporting-rules-tab">
    <div class="mt-2">
      <ul class="nav nav-pills mb-3" id="pills-tab" role="tablist">
          <li class="nav-item success">
              <a class="nav-link active" id="pills-ICSR-tab" data-toggle="pill"
                  href="#pills-ICSR" role="tab" aria-controls="pills-ICSR"
                  aria-selected="true">Expedited ICSR Reporting Rules</a>
          </li>
          <li class="nav-item">
              <a class="nav-link" id="pills-SRC-status-tab" data-toggle="pill"
                  href="#pills-SRC-status" role="tab" aria-controls="pills-SRC-status"
                  aria-selected="false">ICSR SRC-non SRC status</a>
          </li>

      </ul>
      <div class="tab-content" id="pills-tabContent">
          <div class="tab-pane fade show active" id="pills-ICSR" role="tabpanel"
              aria-labelledby="pills-ICSR-tab">
              <h4 class="mb-3"> Medicinal Product - Expedited Reporting Rules </h4>
              
              <div class="alert alert-success alert-dismissible fade show" role="alert" style="font-size:13px">
                      <p>
                          <u>ICSR Strongly Regulated Countries (SRC)</u> = Local expedited reporting regulatory requirements for MAH/sponsor. The Reporting rules provide local requirements to ensure further ICSR submission to local/regional Health Authority <Br>
                          <u>ICSR non Strongly Regulated Countries (NSRC)</u> = No local expedited reporting regulatory requirements to HA for MAH/sponsor. The Reporting rules are configured so that Local PV representatives (e.g .CSL), receive, for information only, CIOMS-I form of local ICSR.                                                 </p>
                      <hr>
                      <ul>
                          <li>EEA = From any EEA Member States (i.e. 28 Member States of the European Union + Iceland, Liechtenstein, Norway)</li>
                          <li>exEEA = Outside the EEA </li>
                          <li>EEU = EurAsia, China & JPACn Economic Union (=Armenia, Belarus, Kazakhstan, Kyrgyzstan, Russia) </li>
                          <li>exEEU = Outside the EEU </li>
                      </ul>

                  </div>
                  <div class="alert alert-info alert-dismissible fade show" role="alert" style="font-size:13px">
                          <b>1ICSR collection type</b> could be <br>
                          - <b>Unsolicited</b> - refers to ADR originating from unsolicited source such as spontaneous notification, digital media, literature and prospective or retrospective disease registries or cohort. <br>
                          - <b>Solicited</b> - refers to AE originating from solicited source such as:  
                          <ul>
                                  <li>Interventional clinical trials and compassionate use with a non-registered product: Solicited (CT)</li>
                                  <li> Post-authorization non interventional clinical study, compassionate use (with a registered product), prospective or retrospective product registries or cohort with a primary data collection form, patient support programs, named patient programs and market research programs: Solicited (PM)</li>
                              </ul>
                              <b>2Submission Rule</b> : The ICSR reporting to Regulatory Authority follows one of the following rules and depends on the ICSR collection: <br>
                          - CT Rule : interventional clinical trials reporting legislation <br>
                          - PM Rule: post marketing PV legislation 
                      <hr>
                          <strong>3Related criteria in the unsolicited reporting rules: </strong> any report notified spontaneously is considered as a reaction, ie related to the medicinal product <br>
                          <b>4Unexpectedness criteria : </b>  <br>
                          - When Unexpected ICSR should be submitted as per local SPC, all ISCR will be released to the affiliate so that the listedness is done as per local SPC and not as per CCSI. <br>
                          - When Unexpected ICSR should be submitted as per local CCSI, only unexpected ISCR will be released to the affiliate. <br>

                      <strong> 5Medically Confirmed </strong> : applicable only for unsolicited RR, since all solicited ICSR are reported by investigators.

                      <hr>

                      <b>6Timeslines - if only days specified, should be considered as calendar days. day</b> = cd <br>
                      -<b>PM submission rule</b>  :e.g 15 days/ 90 days timelines = 15 day for serious / 90 days for non serious     <br>
                      - <b>CT submission rule</b> : e.g. 7 days/ 15 days timelines = 7 day for D/LT / 15 days for other seriouness criteria <br>
                      - Other timelines clarified in the comment section.


                  </div>

              <div class="table-responsive">
                  <table id="dtHorizontal" class="table table-hover table-striped pharma_table">
                      <thead>
                          <tr>
                              <th>Region</th>
                              <th style="width:100px">Country</th>
                              <th>Site Name</th>
                              <th>ICSR Strongly Regulated Site</th>
                              <th>Collection Type1</th>
                              <th>Submission Rule2</th>
                              <th>Serious (S)/Non-Serious (NS)</th>
                              <th>Related3 (R)/ Not Related (NR)</th>
                              <th>Unexpected Only4 (U)/Expected- Listed (E) </th>
                              <th>Expectedness Locally Assessed as per SmPC (Y-N/A)</th>
                              <th>Medically Confirmed5 (M )/ Consumer (Co)</th>
                              <th>G / L / F<br> Global (G) = Local (L) + Foreign (F)</th>
                              <th>Report Format</th>
                              <th>Reporting Timelines
                                  cd= calendar days
                                  wd = working days
                                  mo = month</th>
                              <th>Day 0
                                  (Clock start date)
                                  Upon receipt by Company (= first Sanofi employee) or
                                  Affiliate (= at affiliate level [MAH])</th>
                              <th>Translation into Local language required
                                  (Y/N)</th>
                              <th style="width:400px">Comments</th>
                              <th>Date of double-check of the revised information by safety RI
                              </th>
                              <th>Date of sending of the updated reporting rules to CSL </th>
                              <th>CSL Validation date </th>
                              <th>AEGIS implementation date</th>
                          </tr>
                      </thead>
                      <tbody>
                          <tr>
                              <td>Africa, Middle East & Eurasia</td>
                              <td><img src="assets/images/flags/af.png" class="table_flag" />
                                  Afghanistan
                              </td>
                              <td>Afghanistan</td>
                              <td>NO</td>
                              <td>Solicited (CT)</td>
                              <td>CT Rule</td>
                              <td>S</td>
                              <td>R</td>
                              <td>U/E</td>
                              <td>N/A</td>
                              <td>M</td>
                              <td>L</td>
                              <td>CIOMS </td>
                              <td>N/A</td>
                              <td>N/A</td>
                              <td>N/A</td>
                              <td></td>
                              <td>16-Aug-2018</td>
                              <td>2-Mar-2018</td>
                              <td>8-Mar-2018</td>
                              <td>22-May-2018</td>
                          </tr>
                          <tr>
                              <td>Africa, Middle East & Eurasia</td>
                              <td><img src="assets/images/flags/af.png" class="table_flag" />
                                  Afghanistan</td>
                              <td>Afghanistan</td>
                              <td>YES</td>
                              <td>UnSolicited <br>
                                  Solicited (PM)</td>
                              <td>PM Rule</td>
                              <td>S/NS</td>
                              <td>R</td>
                              <td>U/E</td>
                              <td>N/A</td>
                              <td>M/Co</td>
                              <td>L</td>
                              <td>CIOMS I </td>
                              <td>Not Specified</td>
                              <td>Company</td>
                              <td>N</td>
                              <td>Local manufacturers, exporters, importers, and distributors
                                  of medicines and their authorized representatives in
                                  Afghanistan will be required to keep records of all adverse
                                  reactions and interactions of medicines reported to them and
                                  submit such reports to the Pharmacovigilance unit of
                                  Medicine National Information Centre</td>
                              <td>16-Aug-2018</td>
                              <td>2-Mar-2018</td>
                              <td>8-Mar-2018</td>
                              <td>22-May-2018</td>
                          </tr>
                          <tr>
                              <td>Europe non EEA</td>
                              <td><img src="assets/images/flags/al.png" class="table_flag" /> Albania
                              </td>
                              <td>Albania</td>
                              <td>YES</td>
                              <td>Solicited (CT)</td>
                              <td>CT Rule</td>
                              <td>S</td>
                              <td>R</td>
                              <td>U/E</td>
                              <td>N/A</td>
                              <td>M</td>
                              <td>L</td>
                              <td>CIOMS I </td>
                              <td>15 cd</td>
                              <td>Company</td>
                              <td>N</td>
                              <td></td>
                              <td>16-Aug-2018</td>
                              <td>2-Mar-2018</td>
                              <td>8-Mar-2018</td>
                              <td>22-May-2018</td>
                          </tr>
                      </tbody>
                  </table>
              </div>
          </div>
          <div class="tab-pane fade" id="pills-SRC-status" role="tabpanel"
              aria-labelledby="pills-SRC-status-tab">

              <table class="table table-hover table-striped pharma_table">
                  <thead>
                      <tr>
                          <th>Region</th>
                          <th>ICSR Strongly Regulated Site</th>
                          <th>Submission Rule2</th>
                          <th>Country</th>
                      </tr>
                  </thead>
                  <tbody>
                      <tr>
                          <td>Africa, Middle East & Eurasia</td>
                          <td>NO</td>
                          <td>CT Rule</td>
                          <td>
                                  Afghanistan <br>
                                  Angola<br>
                                  Armenia<br>
                                  Azerbaidjan<br>
                                  Bahrain<br>
                                  Benin<br>
                                  Burundi<br>
                                  Cape Verde<br>
                                  Central African Republic<br>
                                  Chad<br>
                                  Comoros<br>
                                  Congo<br>
                                  Democratic rep of Congo<br>
                                  Djibouti<br>
                                  Equatorial Guinea<br>
                                  Eritrea<br>
                                  Ethiopia<br>
                                  Gabon<br>
                          </td>
                      </tr>
                      <tr>
                          <td>Americas</td>
                          <td>NO</td>
                          <td>CT Rule</td>
                          <td>
                                  Aruba<br>
                                  Bahamas<br>
                                  Barbados<br>
                                  Belize<br>
                                  Bermuda<br>
                                  Costa Rica<br>
                                  Curacao<br>
                                  DOMINICAN REPUBLIC<br>
                                  Ecuador<br>
                                  El Salvador<br>
                                  Guatemala<br>
                                  Haiti<br>
                                  Honduras<br>
                                  Jamaica<br>
                                  Netherlands Antilles<br>
                                  Nicaragua<br>
                                  Paraguay<br>
                                  Trinidad &Tobago<br>
                                  Uruguay<br>
                          </td>
                      </tr>
                  </tbody>
              </table>
          </div>
      </div>
  </div>
  </div>
  <div class="tab-pane fade" id="national-periodic-reporting-requirements" role="tabpanel" aria-labelledby="national-periodic-reporting-requirements-tab">
    <div class="mt-2">
      <h5 class="text-center">Periodic Reports
              Post Marketing :<br/>Periodic Benefit-Risk Evaluation Report (PBRER) / other report or Line-listing
              Development Phase:<br/>Development Safety Update Report (DSUR)/ Semi-Annual Safety Report (SASR) / other report or Line-listing
      </h5>
      <br/>
      <div class="alert alert-info alert-dismissible fade show" role="alert" style="font-size:13px">
              <strong>Reports required </strong>=  local regulation requirement<br/>
              <strong>Semi-Annual Safety Report (SASR) </strong>=  line-listing of all SUSARs accompanied by a brief summary of main points of safety concerns from the IP - 6-monthly basis [formerly Named PSS]<br/>
              <strong>EC  </strong>= Ethic Committee / <strong>HA  </strong>= Heatlh Authority<br/>

      </div>
      <table class="table table-striped table-hover pharma_table">
              <thead>
                <tr>
                  <th scope="col">Region</th>
                  <th scope="col">Country</th>
                  <th scope="col">Periodic Report PM/CT</th>
                  <th scope="col">Type of Report</th>
                  <th scope="col">Reporting Timelines after DLP</th>
                  <th scope="col">DLP Alignment</th>
                  <th scope="col">Periodicity</th>
                  <th scope="col">HA submission required YES/ NO/Upon request</th>
                  <th scope="col">EC submission required YES/ NO</th>
                  <th scope="col">Investigator submission required YES/ NO</th>
                  <th scope="col">Comment</th>
                  <th scope="col">Global contribution YES/NO</th>
                  <th scope="col">Date of Review at global</th>
                  <th scope="col">Local validation/ confirmation date</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Africa, Middle East & Eurasia</td>
                  <td class="bold">Afghanistan</td>
                  <td class="bold">CT</td>
                  <td>None</td>
                  <td>N/A</td>
                  <td>N/A</td>
                  <td>N/A</td>
                  <td>N/A</td>
                  <td>N/A</td>
                  <td>N/A</td>
                  <td>N/A</td>
                  <td>N/A</td>
                  <td>8/1/2016</td>
                  <td></td>
                 </tr>
              </tbody>
          </table>

  </div>
  </div>
  <div class="tab-pane fade" id="responsibiilty-per-country" role="tabpanel" aria-labelledby="responsibiilty-per-country-tab">
    <div class="mt-2">
      <h5 class="center">SUMMARY OF RESPONSIBILITY PER COUNTRY FOR THE SAFETY REPORTING OBLIGATIONS<br/>IN A INTERVENTIONAL CLINICAL TRIAL 
          (EXPEDITED ICSRs and PERIODIC CLINICAL STUDY SAFETY REPORT)					
      </h5>
      <br/>
      <div class="alert alert-success" role="alert" style="font-size:13px">
          <p>
              The summary of Responsibility per Country for the Safety Reporting Obligations has been also established when a CRO has been subcontracted in a clinical trial. 
          </p>
          <hr>
          <p class="mb-0">For any update in a regulation or sharing of responsibility during a clinical trial, the CSH, Clinical Safety Unit Safety Lead or equivalent should inform:</p>
          <ul>
              <li>GPV QPPV office - Safety Regulatory Intelligence to update the table</li>
              <li>CRO to update the contract</li>
          </ul>
      </div>
      <div class="alert alert-info alert-dismissible fade show" role="alert" style="font-size:13px">
              <strong>ICSR </strong>=  Individual Case Safety Report<br/>
              <strong>SUSAR </strong>=  Suspected Unexpected Serious Adverse Reaction<br/>
              <strong>SSAR </strong>=  Semi Annual Safety Report<br/>
              <strong>DSUR </strong>=  Development Safety Update Report<br/>
          <hr>
              <strong>In case of sharing of responsibility with CRO, it might that specific interface should be implemented locally due to the national regulatory requirement. The below option can be chosen for a safety report:</strong><br/>
                  <strong><i>(a)</i></strong> CRO will forward Sanofi country of a copy of AE/ SAE form from the country.  So that Sanofi country will be able to prepare and submit the expedited/line-listing/periodic ICSR to Health Authority (HA).<br/>					
                  <strong><i>(b)</i></strong> CRO will inform Sanofi country of a traceability of SUSAR/ Periodic Report submitted to Ethic Committee (EC)<br/>					
                  <strong><i>(c)</i></strong> Sanofi country will inform/submit CRO of a traceability of ICSR - Expedited and Periodic Report submitted to HA.<br/> 
                  <strong><i>(d)</i></strong> Sanofi country will inform CRO of ICSR to be submitted to EC<br/>
                  <strong><i>(e)</i></strong> CRO will inform Sanofi country of a traceability of safety report (e.g. SUSAR, DSUR and Quarterly) submitted to HA, and when required Sanofi country will forward CRO a copy of required CIOMS forms
              

      </div>

      <table class="table table-striped table-hover pharma_table">
              <thead>
                <tr>
                  <th scope="col">Region</th>
                  <th scope="col">Country</th>
                  <th scope="col">CRO</th>
                  <th scope="col">Health Authority Submission</th>
                  <th scope="col">Central Ethic Committee Submission</th>
                  <th scope="col">Local Ethic Committee Submission</th>
                  <th scope="col">Investigators Distribution</th>
                  <th scope="col">Date of Review at global</th>
                  <th scope="col">Local validation/Confimation Date</th>
                  <th scope="col">Comment</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>All Regions</td>
                  <td class="bold">All countries</td>
                  <td class="bold">CRO</td>
                  <td>Local SANOFI</td>
                  <td>CRO name or Sanofi Country</td>
                  <td>Principal Investigator via CRO name</td>
                  <td>CRO</td>
                  <td>17-Jul-2013</td>
                  <td></td>
                  <td></td>
                 </tr>
                 <tr>
                      <td>All Regions</td>
                      <td class="bold">All countries</td>
                      <td class="bold">RR</td>
                      <td>> new safety finding</td>
                      <td>> new safety finding</td>
                      <td>> DIL - new safety finding</td>
                      <td>> DIL - new safety finding</td>
                      <td>17-Jul-2013</td>
                      <td></td>
                      <td></td>
                  </tr>
                <tr>
                  <td>Africa, Middle East & Eurasia</td>
                  <td class="bold">Afghanistan</td>
                  <td class="bold">CRO</td>
                  <td>Not Applicable</td>
                  <td>Not Applicable</td>
                  <td>Principal Investigator via CRO</td>
                  <td>CRO</td>
                  <td>1-Aug-2016</td>
                  <td></td>
                  <td></td>
                 </tr>
                 <tr>
                      <td>Africa, Middle East & Eurasia</td>
                      <td class="bold">Afghanistan</td>
                      <td class="bold">RR</td>
                      <td>Not Applicable</td>
                      <td>Not Applicable</td>
                      <td>> DIL - SUSAR  Blinded</td>
                      <td>> DIL - SUSAR Blinded</td>
                      <td>1-Aug-2016</td>
                      <td></td>
                      <td></td>
                     </tr>
              <tr>
                  <td>Europe non EEA</td>
                  <td class="bold">Albania</td>
                  <td class="bold">CRO</td>
                  <td>AL SANOFI</td>
                  <td>Not Applicable</td>
                  <td>Principal Investigator via CRO</td>
                  <td>CRO</td>
                  <td>26-Sep-2013</td>
                  <td></td>
                  <td></td>
                 </tr>
              </tbody>
            </table>
  </div>
  </div>
  <div class="tab-pane fade" id="national-rmp-requirements" role="tabpanel" aria-labelledby="national-rmp-requirements-tab">
    <div class="mt-2">
      <ul class="nav nav-pills mb-3" id="pills-tab" role="tablist">
              <li class="nav-item success">
                  <a class="nav-link active" id="pills-requirement-tab" data-toggle="pill" href="#pills-requirement" role="tab" aria-controls="pills-requirement" aria-selected="true">RMP requirement</a>
              </li>
              <li class="nav-item">
                  <a class="nav-link" id="pills-Status-tab" data-toggle="pill" href="#pills-Status" role="tab" aria-controls="pills-Status" aria-selected="false">RMP Status per region</a>
              </li>
              <li class="nav-item">
                  <a class="nav-link" id="pills-types-tab" data-toggle="pill" href="#pills-types" role="tab" aria-controls="pills-types" aria-selected="false">RMP Type</a>
              </li>
              <li class="nav-item">
                  <a class="nav-link" id="pills-Format-tab" data-toggle="pill" href="#pills-Format" role="tab" aria-controls="pills-Format" aria-selected="false">RMP Format</a>
              </li>
          </ul>
          <div class="tab-content" id="pills-tabContent">
              <div class="tab-pane fade show active" id="pills-requirement" role="tabpanel" aria-labelledby="pills-requirement-tab">

                      <h3>Risk Management Plan Requirements</h3>
                      <br/>
                      <table class="table table-striped table-hover pharma_table">
                        <thead>
                          <tr>
                            <th>Region</th>
                            <th style="min-width:100px">Country</th>
                            <th>Risk Management Plan Required</th>
                            <th>Type of Risk Management Plan</th>
                            <th>Risk Management Plan Format</th>
                            <th>Summary RMP - Public</th>
                            <th>Comments</th>
                            <th>Date of Review at Global</th>
                            <th>Local Confirmation/Validation Date</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td>Africa, Middle East & Eurasia</td>
                            <td><img src="assets/images/flags/af.png" class="table_flag"/> Afghanistan</td>
                            <td>NO</td>
                            <td>NA</td>
                            <td>NA</td>
                            <td>NA</td>
                            <td></td>
                            <td>1-Aug-2016</td>
                            <td></td>
                          </tr>
                          <tr>
                            <td>Europe non EEA</td>
                            <td><img src="assets/images/flags/al.png" class="table_flag"/> Albania</td>
                            <td>NO</td>
                            <td>NA</td>
                            <td>NA</td>
                            <td>NA</td>
                            <td></td>
                            <td>19-Apr-2015</td>
                            <td>15-Jun-2015</td>
                          </tr>
                          <tr>
                            <td>Europe non EEA</td>
                            <td><img src="assets/images/flags/dz.png" class="table_flag"/> Algeria</td>
                            <td>NO</td>
                            <td>NA</td>
                            <td>NA</td>
                            <td>NA</td>
                            <td></td>
                            <td>19-Apr-2015</td>
                            <td>No answer</td>
                          </tr>
                          <tr>
                            <td>Europe non EEA</td>
                            <td><img src="assets/images/flags/ao.png" class="table_flag"/> Angola</td>
                            <td>NO</td>
                            <td>NA</td>
                            <td>NA</td>
                            <td>NA</td>
                            <td></td>
                            <td>19-Apr-2015</td>
                            <td>No answer</td>
                          </tr>
                          <tr>
                            <td>Americas</td>
                            <td><img src="assets/images/flags/ar.png" class="table_flag"/> Argentina</td>
                            <td>YES</td>
                            <td>RMP</td>
                            <td>Local Format (e.g. EU old format)</td>
                            <td>NO</td>
                            <td>"RMP in local format required with the application for authorization of:<br/>
                              - new active pharmaceutical ingredient <br/>
                              - a biologic product, included vaccines<br/>
                              - a similar product for which the reference product requires RMP activities <br/>
                              -a fixed association without marketing evidence in a list of countries<br/>
                              - upon HA request <br/>
                              - a product to be registered upon special circumstances (e.g. orphan drug)<br/>
                              - in case of significant changes to the medicinal product (new dosage, indication) "
                              </td>
                            <td>19-Apr-2015</td>
                            <td>15-Jun-2015</td>
                          </tr>
                        </tbody>
                      </table>
              </div>
              <div class="tab-pane fade" id="pills-Status" role="tabpanel" aria-labelledby="pills-Status-tab">
                      <table class="table table-striped table-hover pharma_table">
                        <thead>
                          <tr>
                            <th>Region</th>
                            <th>YES</th>
                            <th>Upon request</th>
                            <th>Planned</th>
                            <th>NO</th>
                            <th>Total général</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td>Europe EEA</td>
                            <td>31</td>
                            <td></td>
                            <td></td>
                            <td></td>
                            <td>31</td>
                          </tr>
                          <tr>
                              <td>Europe non EEA</td>
                              <td>4</td>
                              <td></td>
                              <td></td>
                              <td>4</td>
                              <td>8</td>
                          </tr>
                          <tr>
                              <td>Africa, Middle East & Eurasia</td>
                              <td>24</td>
                              <td>5</td>
                              <td>3</td>
                              <td>50</td>
                              <td>82</td>
                          </tr>
                          <tr>
                              <td>Americas</td>
                              <td>12</td>
                              <td>5</td>
                              <td></td>
                              <td>14</td>
                              <td>31</td>
                          </tr>
                          <tr>
                              <td>Asia, China & JPAC</td>
                              <td>12</td>
                              <td>1</td>
                              <td>1</td>
                              <td>10</td>
                              <td>24</td>
                          </tr>
                          <tr class="table-secondary bold">
                              <td>Total général</td>
                              <td>83</td>
                              <td>11</td>
                              <td>4</td>
                              <td>78</td>
                              <td>176</td>
                          </tr>
                        </tbody>
                      </table>

                      <img src="/assets/images/RMPStatus.JPG" />

              </div>
              <div class="tab-pane fade" id="pills-types" role="tabpanel" aria-labelledby="pills-types-tab">
                  <table class="table table-striped pharma_table">
                      <thead>
                        <tr>
                          <th>Étiquettes de lignes
                          </th>
                          <th>Nombre de Country
                          </th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td>RMP</td>
                          <td>82</td>
                        </tr>
                        <tr>
                            <td>REMS</td>
                            <td>1</td>
                        </tr>
                        <tr>
                            <td>RMP or REMS</td>
                            <td>4</td>
                        </tr>
                        <tr>
                            <td>PV Plan or RMP</td>
                            <td>5</td>
                        </tr>
                        <tr>
                            <td>PV Plan</td>
                            <td>2</td>
                        </tr>
                        <tr>
                          <td>Planned</td>
                          <td>4</td>
                        </tr>
                        <tr class="table-secondary bold">
                          <td>Total général</td>
                          <td>4</td>
                        </tr>
                      </tbody>
                    </table>

                    <img src="/assets/images/RMPType.JPG" />
              </div>
              <div class="tab-pane fade" id="pills-Format" role="tabpanel" aria-labelledby="pills-Format-tab">

                  <img src="/assets/images/RMPFormat.JPG" style="border:1px solid #ccc; float:left"/>

                  <table class="table table-hover table-striped pharma_table" style="float:left; width: 700px; margin-left: 20px;">
                      <thead>
                        <tr>
                          <th>Étiquettes de lignes
                          </th>
                          <th>Nombre de Country
                          </th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td>EU Format</td>
                          <td>53</td>
                        </tr>
                        <tr>
                            <td>EU or US Format</td>
                            <td>4</td>
                        </tr>
                        <tr>
                            <td>Not Specified</td>
                            <td>25</td>
                        </tr>
                        <tr>
                            <td>US Format</td>
                            <td>1</td>
                        </tr>
                        <tr>
                            <td>Local Format (e.g. EU old format)</td>
                            <td>11</td>
                        </tr>
                        <tr class="table-secondary bold">
                          <td>Total général</td>
                          <td>94</td>
                        </tr>
                      </tbody>
                    </table>

                    
              </div>
          </div>
</div>
  </div>
</div>

</div>